Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of FABALOFEN 60 vs JAPROLOX in Healthy Subjects
NCT04386122Phase 1Completed
- Start
- May 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of loxoprofen in pain and inflammation (2 arms). Primary endpoints: Area Under the Curve from time 0 to last measurable concentration, Maximum Serum Concentration and 1 more. Started May 2020; status: completed.
02
Drugs
loxoprofen
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT04386122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04386122.